There is a visibility gap in healthcare. The current reactive approach drives this gap, as individuals tend to seek treatment only when they experience symptoms. Unfortunately, this reactive model leads to higher medical costs and compromised overall well-being. To address this pressing issue, there is an urgent need for a proactive approach that creates transparency by focusing on early detection, personalized care, and predictive health analytics. By shifting the healthcare system’s focus towards prevention and empowering individuals with actionable insights, we can bring about a transformation that improves outcomes while reducing costs.

One company at the forefront of this transformative movement is Molecular You, specializing in predictive health analytics that provide unprecedented transparency into health at the molecular level. They are revolutionizing the healthcare landscape with their innovative platform and a team of industry experts who share a common mission to reshape our approach to health.

Meet the Team

At the forefront of Molecular You’s leadership team is CEO Jim Kean, a senior technology executive who brings a diverse background and wealth of experience to his role at Molecular You. With a focus on consumer-oriented health experiences, Kean has held key roles at prominent organizations such as Cambia Health and WellnessFx™. His career highlights include driving the development of a next-generation consumer engagement platform at Cambia Health, a Blue Cross Blue Shield insurer. Additionally, Kean served as the General Manager of Value Management, where he focused on population health analytics.

Before his tenure at Cambia Health, Kean made significant contributions to the field of consumer health communities during his involvement with WebMD. As the founder and President of Sapient Health Network (SHN), which became the consumer-facing business of WebMD, he pioneered the concept of online consumer health communities. Under his leadership, SHN built some of the largest and most loyal groups on the web, providing valuable health resources and fostering a sense of community among users.

Working alongside Jim is Dr. Rob Fraser, a renowned expert in personalized medicine and molecular diagnostics, who serves as the Chief Scientific Officer and President of Molecular You. Dr. Fraser’s involvement in various drug discovery and development projects, including his role in the influential Personalized Medicine Initiative, showcases his dedication to pushing the boundaries of medical innovation. 

Dr. Fraser’s academic background and research accomplishments further attest to his expertise in personalized medicine. With extensive training in the molecular mechanisms of endocrinology, including his Ph.D. from the University of Alberta and Harvard Medical School, as well as post-doctoral fellowships at renowned institutions such as the Hospital for Sick Children in Toronto and IGBMC in Strasbourg, France, Dr. Fraser brings a strong scientific foundation to his role, positioning him as a key figure in Molecular You’s pursuit of revolutionizing healthcare through predictive health analytics.

Completing the leadership team is Dr. David Wishart, the Chief Informatics Officer and co-founder of Molecular You, who brings a wealth of academic and research experience to the table. Dr. Wishart’s leadership roles at the University of Alberta and the Canadian National Research Council underscore his expertise and influence in the field of molecular diagnostics. As a professor in the Department of Biological Sciences and Computing Science at the University of Alberta, he actively engages in cutting-edge research at the intersection of biology and informatics. Additionally, as the Nano Life Science program director at the Canadian National Research Council’s National Institute for Nanotechnology, Dr. Wishart leads research initiatives at the forefront of scientific innovation.

One of Dr. Wishart’s notable contributions to the field is his involvement in the Human Metabolome Project (HMP). From 2006 to 2009, he led this ambitious multi-university, multi-investigator project that cataloged all known metabolites in human tissues and bio-fluids. Dr. Wishart and his colleagues used advanced methods to identify or find evidence for more than 8500 endogenous metabolites. This groundbreaking work laid the foundation for clinical metabolomics and has profoundly impacted our understanding of human health and disease.

The Platform

Founded in 2014 by Pieter Cullis, OC, FRS and Rob Fraser, Molecular You is a Vancouver-based company specializing in predictive health analytics. They offer a cutting-edge blood testing platform that enables early detection of health risks and provides personalized insights. Using AI-assisted quantitative proteomics and metabolomic testing, Molecular You analyzes hundreds of blood biomarkers from a single draw, providing a comprehensive view of an individual’s pre-symptomatic health trends.

The company’s platform allows users to access Health Scores, assessing their health across 26 different areas. Derived from the blood test results, these scores offer valuable information about disease risks and overall health status.

Beyond test results, Molecular You provides tailored recommendations based on each individual’s unique body and health profile. Users receive specific advice on diet, supplements, and exercise that are most effective for their situation.

Moreover, Molecular You offers dedicated support through 1-on-1 video sessions with health coaches. These sessions assist individuals in staying on track with their health goals and implementing the recommended changes, aiming for meaningful improvements in health outcomes.

Molecular You understands the existing challenges with health visibility within our healthcare system and strongly emphasizes proactive and predictive healthcare. For health care and benefit professionals, the company takes the powerful insights that it can generate for its individual users and is able to provide cutting-edge, deep insights into populations of consumers and patients for over 26 categories of disease. By bridging the gap between assumptions and reality, they leverage technology to reduce costs and enhance health transparency. This approach benefits individuals by promoting overall well-being and empowers companies to mitigate health risks while reducing healthcare plan expenses.

In summary, Molecular You boasts an exceptional team that combines scientific excellence, data science, and AI expertise. With a shared dedication to improving healthcare and a mission to make proactive and predictive healthcare accessible to all, Molecular You is poised to make a significant impact on preventive health and personalized care. By empowering individuals to take control of their health and making the health of a population transparent to payers and practitioners, Molecular You aims to revolutionize healthcare through its cutting-edge platform. To learn more, visit www.molecularyou.com.